Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 12, 2021
[Strategy with Immune Checkpoint Inhibitors for ES‒SCLC]Shigeru Tanzawa, Nobuhiko SekiGan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2011
[CPT-11 chemotherapy for a hemodialysis patient with small-cell lung cancer]Ryozou Gen, Yusuke Shikama, Shigeru Tanzawa, et al.Microbial Pathogenesis|May 13, 2023
Staphylococcus haemolyticus attenuates the antibacterial effect of teicoplanin via aggregates and biofilmsYoshinori Sato, Nami Hatayama, Shigeru Tanzawa, et al.Thoracic Cancer|January 15, 2021
Real-world efficacy of atezolizumab in non-small cell lung cancer: A multicenter cohort study focused on performance status and retreatment after failure of anti-PD-1 antibodyNaoki Furuya, Makoto Nishino, Kazushige Wakuda, et al.Cancers|December 10, 2021
Effect of Adjuvant and Palliative Chemotherapy in Large Cell Neuroendocrine Carcinoma of the Lung: A Systematic Review and Meta-AnalysisHao Chen, Masashi Ishihara, Nobuyuki Horita, et al.Cancers|October 13, 2021
Effectiveness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Systematic Review and Meta-AnalysisHao Chen, Masashi Ishihara, Nobuyuki Horita, et al.Cancer Medicine|September 3, 2024
Efficacy and safety of pharmacotherapy for cancer cachexia: A systematic review and network meta-analysisHao Chen, Masashi Ishihara, Hiroki Kazahari, et al.Translational Lung Cancer Research|February 11, 2021
Pretreatment neutrophil-to-lymphocyte ratio predicts treatment efficacy and prognosis of cytotoxic anticancer drugs, molecular targeted drugs, and immune checkpoint inhibitors in patients with advanced non-small cell lung cancerMasashi Ishihara, Ryosuke Ochiai, Terunobu Haruyama, et al.Case Reports in Oncology|February 13, 2018
A Case of Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Improved by ChemotherapyTakahiko Sakamoto, Shuji Ota, Terunobu Haruyama, et al.Case Reports in Oncology|March 9, 2018
A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and PemetrexedMaika Natsume, Takeshi Honda, Terunobu Haruyama, et al.Pageof 4